352 related articles for article (PubMed ID: 33331637)
1. Use of oral progestogen in women with threatened miscarriage in the first trimester: a randomized double-blind controlled trial.
Chan DMK; Cheung KW; Ko JKY; Yung SSF; Lai SF; Lam MT; Ng DYT; Lee VCY; Li RHW; Ng EHY
Hum Reprod; 2021 Feb; 36(3):587-595. PubMed ID: 33331637
[TBL] [Abstract][Full Text] [Related]
2. Progestogens for preventing miscarriage: a network meta-analysis.
Devall AJ; Papadopoulou A; Podesek M; Haas DM; Price MJ; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013792. PubMed ID: 33872382
[TBL] [Abstract][Full Text] [Related]
3. Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial.
McLindon LA; James G; Beckmann MM; Bertolone J; Mahomed K; Vane M; Baker T; Gleed M; Grey S; Tettamanzi L; Mol BWJ; Li W
Hum Reprod; 2023 Apr; 38(4):560-568. PubMed ID: 36806843
[TBL] [Abstract][Full Text] [Related]
4. A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.
Chan DM; Cheung KW; Yung SS; Lee VC; Li RH; Ng EH
Trials; 2016 Aug; 17(1):408. PubMed ID: 27534747
[TBL] [Abstract][Full Text] [Related]
5. Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.
Coomarasamy A; Harb HM; Devall AJ; Cheed V; Roberts TE; Goranitis I; Ogwulu CB; Williams HM; Gallos ID; Eapen A; Daniels JP; Ahmed A; Bender-Atik R; Bhatia K; Bottomley C; Brewin J; Choudhary M; Crosfill F; Deb S; Duncan WC; Ewer A; Hinshaw K; Holland T; Izzat F; Johns J; Lumsden MA; Manda P; Norman JE; Nunes N; Overton CE; Kriedt K; Quenby S; Rao S; Ross J; Shahid A; Underwood M; Vaithilingham N; Watkins L; Wykes C; Horne AW; Jurkovic D; Middleton LJ
Health Technol Assess; 2020 Jun; 24(33):1-70. PubMed ID: 32609084
[TBL] [Abstract][Full Text] [Related]
6. Progestogen for treating threatened miscarriage.
Wahabi HA; Fayed AA; Esmaeil SA; Bahkali KH
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005943. PubMed ID: 30081430
[TBL] [Abstract][Full Text] [Related]
7. Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial.
Kuptarak A; Phupong V
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2333929. PubMed ID: 38570191
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human granulocyte- colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial.
Eapen A; Joing M; Kwon P; Tong J; Maneta E; De Santo C; Mussai F; Lissauer D; Carter D;
Hum Reprod; 2019 Mar; 34(3):424-432. PubMed ID: 30776296
[TBL] [Abstract][Full Text] [Related]
9. Effect of progestogen for women with threatened miscarriage: a systematic review and meta-analysis.
Li L; Zhang Y; Tan H; Bai Y; Fang F; Faramand A; Chong W; Hai Y
BJOG; 2020 Aug; 127(9):1055-1063. PubMed ID: 32324957
[TBL] [Abstract][Full Text] [Related]
10. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
[TBL] [Abstract][Full Text] [Related]
11. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 infection in the first trimester and the risk of early miscarriage: a UK population-based prospective cohort study of 3041 pregnancies conceived during the pandemic.
Balachandren N; Davies MC; Hall JA; Stephenson JM; David AL; Barrett G; O'Neill HC; Ploubidis GB; Yasmin E; Mavrelos D
Hum Reprod; 2022 May; 37(6):1126-1133. PubMed ID: 35389480
[TBL] [Abstract][Full Text] [Related]
13. Dydrogesterone support in threatened miscarriage.
El-Zibdeh MY; Yousef LT
Maturitas; 2009 Dec; 65 Suppl 1():S43-6. PubMed ID: 20007011
[TBL] [Abstract][Full Text] [Related]
14. Supplementation with progestogens in the first trimester of pregnancy to prevent miscarriage in women with unexplained recurrent miscarriage: a systematic review and meta-analysis of randomized, controlled trials.
Saccone G; Schoen C; Franasiak JM; Scott RT; Berghella V
Fertil Steril; 2017 Feb; 107(2):430-438.e3. PubMed ID: 27887710
[TBL] [Abstract][Full Text] [Related]
15. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage.
Siew JYS; Allen JC; Hui CYY; Ku CW; Malhotra R; Østbye T; Tan TC
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():319-324. PubMed ID: 30077119
[TBL] [Abstract][Full Text] [Related]
16. Dydrogesterone in threatened abortion: pregnancy outcome.
Omar MH; Mashita MK; Lim PS; Jamil MA
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):421-5. PubMed ID: 16293412
[TBL] [Abstract][Full Text] [Related]
17. Progestogen for preventing miscarriage.
Haas DM; Ramsey PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD003511. PubMed ID: 24173668
[TBL] [Abstract][Full Text] [Related]
18. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence.
Coomarasamy A; Devall AJ; Brosens JJ; Quenby S; Stephenson MD; Sierra S; Christiansen OB; Small R; Brewin J; Roberts TE; Dhillon-Smith R; Harb H; Noordali H; Papadopoulou A; Eapen A; Prior M; Di Renzo GC; Hinshaw K; Mol BW; Lumsden MA; Khalaf Y; Shennan A; Goddijn M; van Wely M; Al-Memar M; Bennett P; Bourne T; Rai R; Regan L; Gallos ID
Am J Obstet Gynecol; 2020 Aug; 223(2):167-176. PubMed ID: 32008730
[TBL] [Abstract][Full Text] [Related]
19. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
20. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
